Interpace Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of IDXG for the last quarter is 12.29 M USD, and it's 2.10% higher compared to the previous quarter. The net income of Q3 24 is 1.28 M USD.